Lucicebtide (ST101) plus chemoradiation in newly diagnosed GBM patients: Efficacy, pharmacodynamics, and safety from phase 2 window-of-opportunity study. Test set performance of SMART-Risk vs ResNet50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results